 | • レポートコード：D0GIR-00615 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：サービス、ソフトウェア |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、創薬におけるDNAシーケンスの世界市場を広く調査・分析し、今後の市場展望をまとめております。創薬におけるDNAシーケンスの種類別市場規模（マイクロアレイ、ポリメラーゼ連鎖反応（pcr））、用途別市場規模（医薬品、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Thermo Fisher Scientific, Inc.、Roche Diagnostics、Promega Corporation、Sigma-Aldrich Corporation、Illumina, Inc.、Siemens Healthcare Diagnostics、Beckman Coulter (Danaher Corporation)、GVK Biosciences Private Limited、Nanogen, Inc.、Bio-Rad Laboratories, Inc.、454 Life Sciences ・地域別グローバル市場分析 2015年-2020年 ・創薬におけるDNAシーケンスの北米市場（アメリカ、カナダ、メキシコ） ・創薬におけるDNAシーケンスのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・創薬におけるDNAシーケンスのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・創薬におけるDNAシーケンスの南米市場（ブラジル、アルゼンチン） ・創薬におけるDNAシーケンスの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：マイクロアレイ、ポリメラーゼ連鎖反応（pcr） ・用途別分析：医薬品、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The DNA Sequencing In Drug Discovery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global DNA Sequencing In Drug Discovery sales will be xx in 2020 from DNA Sequencing In Drug Discovery million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global DNA Sequencing In Drug Discovery market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the DNA Sequencing In Drug Discovery industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on DNA Sequencing In Drug Discovery and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
DNA Sequencing In Drug Discovery market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, DNA Sequencing In Drug Discovery market has been segmented into:
Microarrays
Polymerase Chain Reaction (pcr) Techniques
By Application, DNA Sequencing In Drug Discovery has been segmented into:
Pharmaceutical
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global DNA Sequencing In Drug Discovery market presented in the report. This section sheds light on the sales growth of different regional and country-level DNA Sequencing In Drug Discovery markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global DNA Sequencing In Drug Discovery market.
The report offers in-depth assessment of the growth and other aspects of the DNA Sequencing In Drug Discovery market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and DNA Sequencing In Drug Discovery Market Share Analysis
DNA Sequencing In Drug Discovery competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, DNA Sequencing In Drug Discovery sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the DNA Sequencing In Drug Discovery sales, revenue and market share for each player covered in this report.
The major players covered in DNA Sequencing In Drug Discovery are:
Thermo Fisher Scientific, Inc.
Roche Diagnostics
Promega Corporation
Sigma-Aldrich Corporation
Illumina, Inc.
Siemens Healthcare Diagnostics
Beckman Coulter (Danaher Corporation)
GVK Biosciences Private Limited
Nanogen, Inc.
Bio-Rad Laboratories, Inc.
454 Life Sciences
Among other players domestic and global, DNA Sequencing In Drug Discovery market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 DNA Sequencing In Drug Discovery Market Overview
1.1 Product Overview and Scope of DNA Sequencing In Drug Discovery
1.2 Classification of DNA Sequencing In Drug Discovery by Type
1.2.1 Global DNA Sequencing In Drug Discovery Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global DNA Sequencing In Drug Discovery Revenue Market Share by Type in 2019
1.2.3 Microarrays
1.2.4 Polymerase Chain Reaction (pcr) Techniques
1.3 Global DNA Sequencing In Drug Discovery Market by Application
1.3.1 Overview: Global DNA Sequencing In Drug Discovery Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pharmaceutical
1.3.3 Other
1.4 Global DNA Sequencing In Drug Discovery Market by Regions
1.4.1 Global DNA Sequencing In Drug Discovery Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of DNA Sequencing In Drug Discovery (2015-2025)
1.4.3 North America (USA, Canada and Mexico) DNA Sequencing In Drug Discovery Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) DNA Sequencing In Drug Discovery Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) DNA Sequencing In Drug Discovery Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) DNA Sequencing In Drug Discovery Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) DNA Sequencing In Drug Discovery Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: DNA Sequencing In Drug Discovery Industry Impact
1.5.1 COVID-19 Potential Implications for the DNA Sequencing In Drug Discovery
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on DNA Sequencing In Drug Discovery
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Thermo Fisher Scientific, Inc.
2.1.1 Thermo Fisher Scientific, Inc. Details
2.1.2 Thermo Fisher Scientific, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Thermo Fisher Scientific, Inc. SWOT Analysis
2.1.4 Thermo Fisher Scientific, Inc. Product and Services
2.1.5 Thermo Fisher Scientific, Inc. DNA Sequencing In Drug Discovery Revenue, Gross Margin and Market Share (2018-2019)
2.2 Roche Diagnostics
2.2.1 Roche Diagnostics Details
2.2.2 Roche Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Roche Diagnostics SWOT Analysis
2.2.4 Roche Diagnostics Product and Services
2.2.5 Roche Diagnostics DNA Sequencing In Drug Discovery Revenue, Gross Margin and Market Share (2018-2019)
2.3 Promega Corporation
2.3.1 Promega Corporation Details
2.3.2 Promega Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Promega Corporation SWOT Analysis
2.3.4 Promega Corporation Product and Services
2.3.5 Promega Corporation DNA Sequencing In Drug Discovery Revenue, Gross Margin and Market Share (2018-2019)
2.4 Sigma-Aldrich Corporation
2.4.1 Sigma-Aldrich Corporation Details
2.4.2 Sigma-Aldrich Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Sigma-Aldrich Corporation SWOT Analysis
2.4.4 Sigma-Aldrich Corporation Product and Services
2.4.5 Sigma-Aldrich Corporation DNA Sequencing In Drug Discovery Revenue, Gross Margin and Market Share (2018-2019)
2.5 Illumina, Inc.
2.5.1 Illumina, Inc. Details
2.5.2 Illumina, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Illumina, Inc. SWOT Analysis
2.5.4 Illumina, Inc. Product and Services
2.5.5 Illumina, Inc. DNA Sequencing In Drug Discovery Revenue, Gross Margin and Market Share (2018-2019)
2.6 Siemens Healthcare Diagnostics
2.6.1 Siemens Healthcare Diagnostics Details
2.6.2 Siemens Healthcare Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Siemens Healthcare Diagnostics SWOT Analysis
2.6.4 Siemens Healthcare Diagnostics Product and Services
2.6.5 Siemens Healthcare Diagnostics DNA Sequencing In Drug Discovery Revenue, Gross Margin and Market Share (2018-2019)
2.7 Beckman Coulter (Danaher Corporation)
2.7.1 Beckman Coulter (Danaher Corporation) Details
2.7.2 Beckman Coulter (Danaher Corporation) Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Beckman Coulter (Danaher Corporation) SWOT Analysis
2.7.4 Beckman Coulter (Danaher Corporation) Product and Services
2.7.5 Beckman Coulter (Danaher Corporation) DNA Sequencing In Drug Discovery Revenue, Gross Margin and Market Share (2018-2019)
2.8 GVK Biosciences Private Limited
2.8.1 GVK Biosciences Private Limited Details
2.8.2 GVK Biosciences Private Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 GVK Biosciences Private Limited SWOT Analysis
2.8.4 GVK Biosciences Private Limited Product and Services
2.8.5 GVK Biosciences Private Limited DNA Sequencing In Drug Discovery Revenue, Gross Margin and Market Share (2018-2019)
2.9 Nanogen, Inc.
2.9.1 Nanogen, Inc. Details
2.9.2 Nanogen, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Nanogen, Inc. SWOT Analysis
2.9.4 Nanogen, Inc. Product and Services
2.9.5 Nanogen, Inc. DNA Sequencing In Drug Discovery Revenue, Gross Margin and Market Share (2018-2019)
2.10 Bio-Rad Laboratories, Inc.
2.10.1 Bio-Rad Laboratories, Inc. Details
2.10.2 Bio-Rad Laboratories, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Bio-Rad Laboratories, Inc. SWOT Analysis
2.10.4 Bio-Rad Laboratories, Inc. Product and Services
2.10.5 Bio-Rad Laboratories, Inc. DNA Sequencing In Drug Discovery Revenue, Gross Margin and Market Share (2018-2019)
2.11 454 Life Sciences
2.11.1 454 Life Sciences Details
2.11.2 454 Life Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 454 Life Sciences SWOT Analysis
2.11.4 454 Life Sciences Product and Services
2.11.5 454 Life Sciences DNA Sequencing In Drug Discovery Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global DNA Sequencing In Drug Discovery Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 DNA Sequencing In Drug Discovery Players Market Share
3.2.2 Top 10 DNA Sequencing In Drug Discovery Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global DNA Sequencing In Drug Discovery Revenue and Market Share by Regions
4.2 North America DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
4.3 Europe DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
4.5 South America DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
5 North America DNA Sequencing In Drug Discovery Revenue by Countries
5.1 North America DNA Sequencing In Drug Discovery Revenue by Countries (2015-2020)
5.2 USA DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
5.3 Canada DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
5.4 Mexico DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
6 Europe DNA Sequencing In Drug Discovery Revenue by Countries
6.1 Europe DNA Sequencing In Drug Discovery Revenue by Countries (2015-2020)
6.2 Germany DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
6.3 UK DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
6.4 France DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
6.5 Russia DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
6.6 Italy DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
7 Asia-Pacific DNA Sequencing In Drug Discovery Revenue by Countries
7.1 Asia-Pacific DNA Sequencing In Drug Discovery Revenue by Countries (2015-2020)
7.2 China DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
7.3 Japan DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
7.4 Korea DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
7.5 India DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
8 South America DNA Sequencing In Drug Discovery Revenue by Countries
8.1 South America DNA Sequencing In Drug Discovery Revenue by Countries (2015-2020)
8.2 Brazil DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
8.3 Argentina DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue DNA Sequencing In Drug Discovery by Countries
9.1 Middle East & Africa DNA Sequencing In Drug Discovery Revenue by Countries (2015-2020)
9.2 Saudi Arabia DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
9.3 UAE DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
9.4 Egypt DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
9.5 South Africa DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global DNA Sequencing In Drug Discovery Revenue and Market Share by Type (2015-2020)
10.2 Global DNA Sequencing In Drug Discovery Market Forecast by Type (2019-2024)
10.3 Microarrays Revenue Growth Rate (2015-2025)
10.4 Polymerase Chain Reaction (pcr) Techniques Revenue Growth Rate (2015-2025)
11 Global DNA Sequencing In Drug Discovery Market Segment by Application
11.1 Global DNA Sequencing In Drug Discovery Revenue Market Share by Application (2015-2020)
11.2 DNA Sequencing In Drug Discovery Market Forecast by Application (2019-2024)
11.3 Pharmaceutical Revenue Growth (2015-2020)
11.4 Other Revenue Growth (2015-2020)
12 Global DNA Sequencing In Drug Discovery Market Size Forecast (2021-2025)
12.1 Global DNA Sequencing In Drug Discovery Market Size Forecast (2021-2025)
12.2 Global DNA Sequencing In Drug Discovery Market Forecast by Regions (2021-2025)
12.3 North America DNA Sequencing In Drug Discovery Revenue Market Forecast (2021-2025)
12.4 Europe DNA Sequencing In Drug Discovery Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific DNA Sequencing In Drug Discovery Revenue Market Forecast (2021-2025)
12.6 South America DNA Sequencing In Drug Discovery Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa DNA Sequencing In Drug Discovery Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global DNA Sequencing In Drug Discovery Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of DNA Sequencing In Drug Discovery by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global DNA Sequencing In Drug Discovery Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market DNA Sequencing In Drug Discovery Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global DNA Sequencing In Drug Discovery Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Thermo Fisher Scientific, Inc. Corporate Information, Location and Competitors
Table 7. Thermo Fisher Scientific, Inc. DNA Sequencing In Drug Discovery Major Business
Table 8. Thermo Fisher Scientific, Inc. DNA Sequencing In Drug Discovery Total Revenue (USD Million) (2017-2018)
Table 9. Thermo Fisher Scientific, Inc. SWOT Analysis
Table 10. Thermo Fisher Scientific, Inc. DNA Sequencing In Drug Discovery Product and Solutions
Table 11. Thermo Fisher Scientific, Inc. DNA Sequencing In Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Roche Diagnostics Corporate Information, Location and Competitors
Table 13. Roche Diagnostics DNA Sequencing In Drug Discovery Major Business
Table 14. Roche Diagnostics DNA Sequencing In Drug Discovery Total Revenue (USD Million) (2018-2019)
Table 15. Roche Diagnostics SWOT Analysis
Table 16. Roche Diagnostics DNA Sequencing In Drug Discovery Product and Solutions
Table 17. Roche Diagnostics DNA Sequencing In Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Promega Corporation Corporate Information, Location and Competitors
Table 19. Promega Corporation DNA Sequencing In Drug Discovery Major Business
Table 20. Promega Corporation DNA Sequencing In Drug Discovery Total Revenue (USD Million) (2017-2018)
Table 21. Promega Corporation SWOT Analysis
Table 22. Promega Corporation DNA Sequencing In Drug Discovery Product and Solutions
Table 23. Promega Corporation DNA Sequencing In Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Sigma-Aldrich Corporation Corporate Information, Location and Competitors
Table 25. Sigma-Aldrich Corporation DNA Sequencing In Drug Discovery Major Business
Table 26. Sigma-Aldrich Corporation DNA Sequencing In Drug Discovery Total Revenue (USD Million) (2017-2018)
Table 27. Sigma-Aldrich Corporation SWOT Analysis
Table 28. Sigma-Aldrich Corporation DNA Sequencing In Drug Discovery Product and Solutions
Table 29. Sigma-Aldrich Corporation DNA Sequencing In Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Illumina, Inc. Corporate Information, Location and Competitors
Table 31. Illumina, Inc. DNA Sequencing In Drug Discovery Major Business
Table 32. Illumina, Inc. DNA Sequencing In Drug Discovery Total Revenue (USD Million) (2017-2018)
Table 33. Illumina, Inc. SWOT Analysis
Table 34. Illumina, Inc. DNA Sequencing In Drug Discovery Product and Solutions
Table 35. Illumina, Inc. DNA Sequencing In Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Siemens Healthcare Diagnostics Corporate Information, Location and Competitors
Table 37. Siemens Healthcare Diagnostics DNA Sequencing In Drug Discovery Major Business
Table 38. Siemens Healthcare Diagnostics DNA Sequencing In Drug Discovery Total Revenue (USD Million) (2017-2018)
Table 39. Siemens Healthcare Diagnostics SWOT Analysis
Table 40. Siemens Healthcare Diagnostics DNA Sequencing In Drug Discovery Product and Solutions
Table 41. Siemens Healthcare Diagnostics DNA Sequencing In Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Beckman Coulter (Danaher Corporation) Corporate Information, Location and Competitors
Table 43. Beckman Coulter (Danaher Corporation) DNA Sequencing In Drug Discovery Major Business
Table 44. Beckman Coulter (Danaher Corporation) DNA Sequencing In Drug Discovery Total Revenue (USD Million) (2017-2018)
Table 45. Beckman Coulter (Danaher Corporation) SWOT Analysis
Table 46. Beckman Coulter (Danaher Corporation) DNA Sequencing In Drug Discovery Product and Solutions
Table 47. Beckman Coulter (Danaher Corporation) DNA Sequencing In Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. GVK Biosciences Private Limited Corporate Information, Location and Competitors
Table 49. GVK Biosciences Private Limited DNA Sequencing In Drug Discovery Major Business
Table 50. GVK Biosciences Private Limited DNA Sequencing In Drug Discovery Total Revenue (USD Million) (2017-2018)
Table 51. GVK Biosciences Private Limited SWOT Analysis
Table 52. GVK Biosciences Private Limited DNA Sequencing In Drug Discovery Product and Solutions
Table 53. GVK Biosciences Private Limited DNA Sequencing In Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Nanogen, Inc. Corporate Information, Location and Competitors
Table 55. Nanogen, Inc. DNA Sequencing In Drug Discovery Major Business
Table 56. Nanogen, Inc. DNA Sequencing In Drug Discovery Total Revenue (USD Million) (2017-2018)
Table 57. Nanogen, Inc. SWOT Analysis
Table 58. Nanogen, Inc. DNA Sequencing In Drug Discovery Product and Solutions
Table 59. Nanogen, Inc. DNA Sequencing In Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Bio-Rad Laboratories, Inc. Corporate Information, Location and Competitors
Table 61. Bio-Rad Laboratories, Inc. DNA Sequencing In Drug Discovery Major Business
Table 62. Bio-Rad Laboratories, Inc. DNA Sequencing In Drug Discovery Total Revenue (USD Million) (2017-2018)
Table 63. Bio-Rad Laboratories, Inc. SWOT Analysis
Table 64. Bio-Rad Laboratories, Inc. DNA Sequencing In Drug Discovery Product and Solutions
Table 65. Bio-Rad Laboratories, Inc. DNA Sequencing In Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. 454 Life Sciences Corporate Information, Location and Competitors
Table 67. 454 Life Sciences DNA Sequencing In Drug Discovery Major Business
Table 68. 454 Life Sciences DNA Sequencing In Drug Discovery Total Revenue (USD Million) (2017-2018)
Table 69. 454 Life Sciences SWOT Analysis
Table 70. 454 Life Sciences DNA Sequencing In Drug Discovery Product and Solutions
Table 71. 454 Life Sciences DNA Sequencing In Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Global DNA Sequencing In Drug Discovery Revenue (Million USD) by Players (2015-2020)
Table 73. Global DNA Sequencing In Drug Discovery Revenue Share by Players (2015-2020)
Table 74. Global DNA Sequencing In Drug Discovery Revenue (Million USD) by Regions (2015-2020)
Table 75. Global DNA Sequencing In Drug Discovery Revenue Market Share by Regions (2015-2020)
Table 76. North America DNA Sequencing In Drug Discovery Revenue by Countries (2015-2020)
Table 77. North America DNA Sequencing In Drug Discovery Revenue Market Share by Countries (2015-2020)
Table 78. Europe DNA Sequencing In Drug Discovery Revenue (Million USD) by Countries (2015-2020)
Table 79. Asia-Pacific DNA Sequencing In Drug Discovery Revenue (Million USD) by Countries (2015-2020)
Table 80. South America DNA Sequencing In Drug Discovery Revenue by Countries (2015-2020)
Table 81. South America DNA Sequencing In Drug Discovery Revenue Market Share by Countries (2015-2020)
Table 82. Middle East and Africa DNA Sequencing In Drug Discovery Revenue (Million USD) by Countries (2015-2020)
Table 83. Middle East and Africa DNA Sequencing In Drug Discovery Revenue Market Share by Countries (2015-2020)
Table 84. Global DNA Sequencing In Drug Discovery Revenue (Million USD) by Type (2015-2020)
Table 85. Global DNA Sequencing In Drug Discovery Revenue Share by Type (2015-2020)
Table 86. Global DNA Sequencing In Drug Discovery Revenue Forecast by Type (2021-2025)
Table 87. Global DNA Sequencing In Drug Discovery Revenue by Application (2015-2020)
Table 88. Global DNA Sequencing In Drug Discovery Revenue Share by Application (2015-2020)
Table 89. Global DNA Sequencing In Drug Discovery Revenue Forecast by Application (2021-2025)
Table 90. Global DNA Sequencing In Drug Discovery Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. DNA Sequencing In Drug Discovery Picture
Figure 2. Global DNA Sequencing In Drug Discovery Revenue Market Share by Type in 2019
Figure 3. Microarrays Picture
Figure 4. Polymerase Chain Reaction (pcr) Techniques Picture
Figure 5. DNA Sequencing In Drug Discovery Revenue Market Share by Application in 2019
Figure 6. Pharmaceutical Picture
Figure 7. Other Picture
Figure 8. Global DNA Sequencing In Drug Discovery Revenue (USD Million) and Growth Rate (2015-2025)
Figure 9. North America DNA Sequencing In Drug Discovery Revenue (Million USD) and Growth Rate (2015-2025)
Figure 10. Europe DNA Sequencing In Drug Discovery Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Asia-Pacific DNA Sequencing In Drug Discovery Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. South America DNA Sequencing In Drug Discovery Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Middle East and Africa DNA Sequencing In Drug Discovery Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Global DNA Sequencing In Drug Discovery Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global DNA Sequencing In Drug Discovery Revenue Share by Players in 2019
Figure 16. Global Top 5 Players DNA Sequencing In Drug Discovery Revenue Market Share in 2019
Figure 17. Global Top 10 Players DNA Sequencing In Drug Discovery Revenue Market Share in 2019
Figure 18. Key Players Market Share Trend
Figure 19. Global DNA Sequencing In Drug Discovery Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 20. Global DNA Sequencing In Drug Discovery Revenue Market Share by Regions (2015-2020)
Figure 21. Global DNA Sequencing In Drug Discovery Revenue Market Share by Regions in 2018
Figure 22. North America DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 23. Europe DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 24. Asia-Pacific DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 25. South America DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 26. Middle East and Africa DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 27. North America DNA Sequencing In Drug Discovery Revenue Market Share by Countries (2015-2020)
Figure 28. North America DNA Sequencing In Drug Discovery Revenue Market Share by Countries in 2019
Figure 29. USA DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 30. Canada DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 31. Mexico DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 32. Europe DNA Sequencing In Drug Discovery Revenue Market Share by Countries (2015-2020)
Figure 33. Europe DNA Sequencing In Drug Discovery Revenue Market Share by Countries in 2019
Figure 34. Germany DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 35. UK DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 36. France DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 37. Russia DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 38. Italy DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 39. Asia-Pacific DNA Sequencing In Drug Discovery Revenue Market Share by Countries (2015-2020)
Figure 40. Asia-Pacific DNA Sequencing In Drug Discovery Revenue Market Share by Countries in 2019
Figure 41. China DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 42. Japan DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 43. Korea DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 44. India DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 45. Southeast Asia DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 46. South America DNA Sequencing In Drug Discovery Revenue Market Share by Countries (2015-2020)
Figure 47. South America DNA Sequencing In Drug Discovery Revenue Market Share by Countries in 2019
Figure 48. Brazil DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 49. Argentina DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 50. Middle East and Africa DNA Sequencing In Drug Discovery Revenue Market Share by Countries (2015-2020)
Figure 51. Middle East and Africa DNA Sequencing In Drug Discovery Revenue Market Share by Countries in 2019
Figure 52. Saudi Arabia DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 53. UAE DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 54. Egypt DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 55. South Africa DNA Sequencing In Drug Discovery Revenue and Growth Rate (2015-2020)
Figure 56. Global DNA Sequencing In Drug Discovery Revenue Share by Type (2015-2020)
Figure 57. Global DNA Sequencing In Drug Discovery Revenue Share by Type in 2019
Figure 58. Global DNA Sequencing In Drug Discovery Market Share Forecast by Type (2021-2025)
Figure 59. Global Microarrays Revenue Growth Rate (2015-2020)
Figure 60. Global Polymerase Chain Reaction (pcr) Techniques Revenue Growth Rate (2015-2020)
Figure 61. Global DNA Sequencing In Drug Discovery Revenue Share by Application (2015-2020)
Figure 62. Global DNA Sequencing In Drug Discovery Revenue Share by Application in 2019
Figure 63. Global DNA Sequencing In Drug Discovery Market Share Forecast by Application (2021-2025)
Figure 64. Global Pharmaceutical Revenue Growth Rate (2015-2020)
Figure 65. Global Other Revenue Growth Rate (2015-2020)
Figure 66. Global DNA Sequencing In Drug Discovery Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 67. Global DNA Sequencing In Drug Discovery Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 68. Global DNA Sequencing In Drug Discovery Revenue Market Share Forecast by Regions (2021-2025)
Figure 69. North America DNA Sequencing In Drug Discovery Revenue Market Forecast (2021-2025)
Figure 70. Europe DNA Sequencing In Drug Discovery Revenue Market Forecast (2021-2025)
Figure 71. Asia-Pacific DNA Sequencing In Drug Discovery Revenue Market Forecast (2021-2025)
Figure 72. South America DNA Sequencing In Drug Discovery Revenue Market Forecast (2021-2025)
Figure 73. Middle East and Africa DNA Sequencing In Drug Discovery Revenue Market Forecast (2021-2025)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
創薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Drug Discovery market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.0% in the forecast period of 2020 to 2025 and will expected to reach USD 51130 million by 2025, from USD 39040 million in 2019. The Drug Discovery market r…- ナノポアシーケンシングの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Nanopore Sequencing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…
- RNAメチル化シーケンスの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The RNA Methylation Sequencing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…
- メチル化RNA免疫沈降シーケンス（MeRIP-Seq）の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global marke…
- ターゲットDNAシーケンスの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Targeted DNA Sequencing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…